Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration
Tomoharu Nishimura, Shigeki Machida, Tomomi Harada, Daijiro KurosakaDepartment of Ophthalmology, Iwate Medical University School of Medicine, Morioka, Iwate, JapanBackground: The purpose of this study was to evaluate the safety of intravitreal ranibizumab injection in patients with age-related macul...
Guardado en:
Autores principales: | Nishimura T, Machida S, Harada T, Kurosaka D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7bd1583d64d4fa88a50b142b40397e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
por: Fujii A, et al.
Publicado: (2014) -
The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki H, et al.
Publicado: (2017) -
Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
por: El-Ashry MF, et al.
Publicado: (2015) -
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sukhpal Singh Sandhu, et al.
Publicado: (2010) -
Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
por: Inoue M, et al.
Publicado: (2014)